RecruitingNot applicableNCT04448951

Immune Homeostasis in Sepsis and Septic Shock

Studying Pituitary stalk interruption syndrome

Last synced from ClinicalTrials.gov March 21, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Charles University, Czech Republic
Principal Investigator: Thomas Karvunidis, MD, PhD
Carles University Teaching Hospital and Faculty of Medicine in Pilsen, Pilsen, Czech Republic
Intervention: transcriptomics(other)
Eligibility: 18 years · All sexes
Timeline: 2020 – 2025

Study locations (1)

Medical ICU, 1st Dept. of Internal Medicine, Teaching Hospital in Pilsen, Pilsen, Česká Republika, Czechia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04448951 on ClinicalTrials.gov

Other trials for Pituitary stalk interruption syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT06368388
Bacteriophage Therapy for Difficult-to-treat Infections: the Implementation of a Multidisciplinary Phage Task Force
Universitaire Ziekenhuizen KU Leuven

See all trials for Pituitary stalk interruption syndrome →

← Back to all trials